Based on gene expression data from a cohort of ovarian cancer datasets, including TCGA29, patients with high CCR1 expression had a shortened disease-free survival compared to patients with low CCR1 expressing tumors. The gene discussed is CCR1; the disease is ovarian carcinoma.